GLP-1Â Uncovered
Join me, Dr. Tyna Moore, in this FREE Training to explore the science behind GLP-1 Agonists. Learn the facts, clear up common misconceptions, and discover their potential benefits - all backed by research and expert insights.
Explore the Potential of GLP-1 Agonists, Beyond Weight Management and Diabetes:
There is increasing discussion about GLP-1 Agonists—a class of peptides commonly used in treatments for weight management and diabetes, including medications such as Ozempic, Wegovy and Mounjaro. However, not every media report reflects rigorous scientific research. Join me as we review current data and examine the scientific evidence behind these compounds. You’ll receive a new video each day along with informative emails that help clarify what the research says.
Beyond Weight Management
Explore potential benefits of GLP1 Agonists that extend beyond weight management. These peptides are under active research for their effects on overall health, and current studies continue to examine their broader applications.
Facts Over Fear
Examine the evidence behind GLP1 Agonists to gain a balanced understanding of common concerns and misconceptions. In this series, I review the available scientific data to help clarify what the research indicates about their use.
The Dose Makes the Poison
Based on clinical observations, side effects may be influenced by dosing levels. Some research suggests that lower doses might be associated with fewer side effects, though individual responses can vary. This approach appears most effective when integrated into a comprehensive health strategy. Always consult a healthcare professional before making any changes to your regimen.
